|
1
|
Foster A and Resnikoff S: The impact of
Vision 2020 on global blindness. Eye (Lond). 19:1133–1135. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Congdon NG, Friedman DS and Lietman T:
Important causes of visual impairment in the world today. JAMA.
290:2057–2060. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Matsubara Y, Murata M, Maruyama T, et al:
Association between diabetic retinopathy and genetic variations in
alpha2beta1 integrin, a platelet receptor for collagen. Blood.
95:1560–1564. 2000.PubMed/NCBI
|
|
4
|
Kunicki TJ, Kritzik M, Annis DS and Nugent
DJ: Hereditary variation in platelet integrin alpha 2 beta 1
density is associated with two silent polymorphisms in the alpha 2
gene coding sequence. Blood. 89:1939–1943. 1997.PubMed/NCBI
|
|
5
|
Early Treatment Diabetic Retinopathy Study
Research Group, . Grading diabetic retinopathy from stereoscopic
color fundus photographs - an extension of the modified Airlie
House classification. ETDRS report number 10. Ophthalmology.
98:786–806. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yau JW, Rogers SL, Kawasaki R, et al
Meta-Analysis for Eye Disease (META-EYE) Study Group: Global
prevalence and major risk factors of diabetic retinopathy. Diabetes
Care. 35:556–564. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hosseini SM, Maracy MR, Amini M and
Baradaran HR: A risk score development for diabetic retinopathy
screening in Isfahan-Iran. J Res Med Sci. 14:105–110.
2009.PubMed/NCBI
|
|
8
|
Ramavat PR, Ramavat MR, Ghugare BW,
Vaishnav RG and Joshi MU: Prevalence of diabetic retinopathy in
western Indian type 2 diabetic population: A hospital-based
cross-sectional study. J Clin Diagn Res. 7:1387–1390.
2013.PubMed/NCBI
|
|
9
|
Delcourt C, Massin P and Rosilio M:
Epidemiology of diabetic retinopathy: Expected vs reported
prevalence of cases in the French population. Diabetes Metab.
35:431–438. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tapp RJ, Shaw JE, Harper CA, et al AusDiab
Study Group: The prevalence of and factors associated with diabetic
retinopathy in the Australian population. Diabetes Care.
26:1731–1737. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Brian G, Fischer-Harder K, et al: Diabetic
eye disease among adults in Fiji with self-reported diabetes. Clin
Experiment Ophthalmol. 38:867–874. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wong TY, Klein R, Islam FM, Cotch MF,
Folsom AR, Klein BE, Sharrett AR and Shea S: Diabetic retinopathy
in a multi-ethnic cohort in the United States. Am J Ophthalmol.
141:446–455. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Klein R, Klein BE, Moss SE and Linton KL:
The Beaver Dam Eye Study. Retinopathy in adults with newly
discovered and previously diagnosed diabetes mellitus.
Ophthalmology. 99:58–62. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ferreiro JL, Gómez-Hospital JA and
Angiolillo DJ: Platelet abnormalities in diabetes mellitus. Diab
Vasc Dis Res. 7:251–259. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
West SK, Muñoz B, Klein R, et al: Risk
factors for Type II diabetes and diabetic retinopathy in a
Mexican-American population: Proyecto VER. Am J Ophthalmol.
134:390–398. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Varma R, Torres M, Peña F, et al Los
Angeles Latino Eye Study Group: Prevalence of diabetic retinopathy
in adult Latinos: The Los Angeles Latino eye study. Ophthalmology.
111:1298–1306. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Polack S, Yorston D, López-Ramos A, et al:
Rapid assessment of avoidable blindness and diabetic retinopathy in
Chiapas, Mexico. Ophthalmology. 119:1033–1040. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
González Villalpando ME, González
Villalpando C, Arredondo Pérez B and Stern MP: Diabetic retinopathy
in Mexico. Prevalence and clinical characteristics. Arch Med Res.
25:355–360. 1994.PubMed/NCBI
|
|
19
|
INEGI, . Statistics About the World
Diabetes Day. National Institute of Statics and Geography.
https://www.inegi.org.mx/inegi/default.aspx?s=inegi&c=2894&pred=1Accessed.
November 14–2013, (In Spanish).
|
|
20
|
The Diabetes Control and Complications
Trial Research Group, . Clustering of long-term complications in
families with diabetes in the diabetes control and complications
trial. Diabetes. 46:1829–1839. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Rema M, Saravanan G, Deepa R and Mohan V:
Familial clustering of diabetic retinopathy in South Indian Type 2
diabetic patients. Diabet Med. 19:910–916. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hallman DM, Huber JC Jr, Gonzalez VH,
Klein BE, Klein R and Hanis CL: Familial aggregation of severity of
diabetic retinopathy in Mexican Americans from Starr County, Texas.
Diabetes Care. 28:1163–1168. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Arar NH, Freedman BI, Adler SG, et al
Family Investigation of Nephropathy and Diabetes Research Group:
Heritability of the severity of diabetic retinopathy: The FIND-Eye
study. Invest Ophthalmol Vis Sci. 49:3839–3845. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Barnett AH: Pathogenesis of diabetic
microangiopathy: An overview. Am J Med. 90((6A)): 67S–73S. 1991.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Petrovic MG, Hawlina M, Peterlin B and
Petrovič D: BglII gene polymorphism of the alpha2beta1 integrin
gene is a risk factor for diabetic retinopathy in Caucasians with
type 2 diabetes. J Hum Genet. 48:457–460. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Buraczynska M, Ksiazek P,
Baranowicz-Gaszczyk I and Jozwiak L: Association of the VEGF gene
polymorphism with diabetic retinopathy in type 2 diabetes patients.
Nephrol Dial Transplant. 22:827–832. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li H, Louey JW, Choy KW, et al: EDN1
Lys198Asn is associated with diabetic retinopathy in type 2
diabetes. Mol Vis. 14:1698–1704. 2008.PubMed/NCBI
|
|
28
|
Costa V, Casamassimi A, Esposito K, et al:
Characterization of a novel polymorphism in PPARG regulatory region
associated with type 2 diabetes and diabetic retinopathy in Italy.
J Biomed Biotechnol. 2009:1269172009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Nakamura S, Iwasaki N, Funatsu H, Kitano S
and Iwamoto Y: Impact of variants in the VEGF gene on progression
of proliferative diabetic retinopathy. Graefes Arch Clin Exp
Ophthalmol. 247:21–26. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Cho H and Sobrin L: Genetics of diabetic
retinopathy. Curr Diab Rep. 14:5152014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Uhlmann K, Kovacs P, Boettcher Y, Hammes
HP and Paschke R: Genetics of diabetic retinopathy. Exp Clin
Endocrinol Diabetes. 114:275–294. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhang T, Pang C, Li N, Zhou E and Zhao K:
Plasminogen activator inhibitor-1 4G/5G polymorphism and
retinopathy risk in type 2 diabetes: A meta-analysis. BMC Med.
11:1–9. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Qian-Qian Y, Yong Y, Jing Z, Dong-Hong F,
et al: Association between a 27-bp variable number of tandem repeat
polymorphism in intron 4 of the eNOS gene and risk for diabetic
retinopathy Type 2 diabetes mellitus: A meta-analysis. Curr Eye
Res. 39:1052–1058. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Abhary S, Hewitt AW, Burdon KP and Craig
JE: A systematic meta-analysis of genetic association studies for
diabetic retinopathy. Diabetes. 58:2137–2147. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Liu L, Yu Q, Wang H, et al: Association of
intercellular adhesion molecule 1 polymorphisms with retinopathy in
Chinese patients with Type 2 diabetes. Diabet Med. 23:643–648.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Qiu M, Xiong W, Liao H and Li F:
VEGF-634G>C polymorphism and diabetic retinopathy risk: A
meta-analysis. Gene. 518:310–315. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
McAuley AK, Wang JJ, Dirani M, et al:
Replication of genetic loci implicated in diabetic retinopathy.
Invest Ophthalmol Vis Sci. 55:1666–1671. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Plow EF, Meller J and Byzova TV: Integrin
function in vascular biology: A view from 2013. Curr Opin Hematol.
21:241–247. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Caunedo-Almagro P: Hemostatic alterations
in diabetes mellitus. Rev Cubana Hematol Inmunol Hemoter. 21:1–9.
2005.(In Spanish).
|
|
40
|
Saboor M, Ayub Q, Ilyas S and Moinuddin:
Platelet receptors: An instrumental of platelet physiology. Pak J
Med Sci. 29:891–896. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Kritzik M, Savage B, Nugent DJ, et al:
Nucleotide polymorphisms in the alpha2 gene define multiple alleles
that are associated with differences in platelet alpha2 beta1
density. Blood. 92:2382–2388. 1998.PubMed/NCBI
|
|
42
|
Expert Committee on the Diagnosis and
Classification of Diabetes Mellitus, . Report of the expert
committee on the diagnosis and classification of diabetes mellitus.
Diabetes Care. 26 (Suppl 1):S5–S20. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Ray D, Mishra M, Ralph S, et al:
Association of the VEGF gene with proliferative diabetic
retinopathy but not proteinuria in diabetes. Diabetes. 53:861–864.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
West SK, Klein R, Rodriguez J, et al
Proyecto VER: Diabetes and diabetic retinopathy in a
Mexican-American population: Proyecto VER. Diabetes Care.
24:1204–1209. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Maghbooli Z, Pasalar P, Keshtkar A,
Farzadfar F and Larijani B: Predictive factors of diabetic
complications: a possible link between family history of diabetes
and diabetic retinopathy. J Diabetes Metab Disord. 13:552014.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Leske MC, Wu SY, Hennis A, et al Barbados
Eye Study Group: Hyperglycemia, blood pressure, and the 9-year
incidence of diabetic retinopathy: The Barbados Eye Studies.
Ophthalmology. 12:799–805. 2005. View Article : Google Scholar
|
|
47
|
Wang FH, Liang YB, Zhang F, et al:
Prevalence of diabetic retinopathy in rural China: The Handan Eye
Study. Ophthalmology. 116:461–467. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Nirmalan PK, Katz J, Robin AL, et al:
Prevalence of vitreoretinal disorders in a rural population of
southern India: The Aravind Comprehensive Eye Study. Arch
Ophthalmol. 122:581–586. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Singh R, Ramasamy K, Abraham C, Gupta V
and Gupta A: Diabetic retinopathy: An update. Indian J Ophthalmol.
56:178–188. 2008.PubMed/NCBI
|
|
50
|
van Leiden HA, Dekker JM, Moll AC, et al:
Blood pressure, lipids, and obesity are associated with
retinopathy: The Hoorn Study. Diabetes Care. 25:1320–1325. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Hallman DM, Boerwinkle E, Gonzalez VH, et
al: A genome-wide linkage scan for diabetic retinopathy
susceptibility genes in Mexican Americans with type 2 diabetes from
Starr County, Texas. Diabetes. 56:1167–1173. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Awata T, Inoue K, Kurihara S, et al: A
common polymorphism in the 5′-untranslated region of the VEGF gene
is associated with diabetic retinopathy in type 2 diabetes.
Diabetes. 51:1635–1639. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Javadi MA, Katibeh M, Rafati N, et al:
Prevalence of diabetic retinopathy in Tehran province: A
population-based study. BMC Ophthalmol. 9:122009. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Martinez-Hervas S, Carmena R, Ascaso JF,
et al: Prevalence of plasma lipid abnormalities and its association
with glucose metabolism in Spain: The di@bet.es study. Clin
Investig Arterioscler. 26:107–114. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Arauz A, Romano JG, Ruiz-Franco A, et al:
Differences in lipid profiles in two Hispanic ischemic stroke
populations. Int J Stroke. 9:394–399. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Escobedo-de la Peña J, de Jesús-Pérez R,
Schargrodsky H and Champagne B: Prevalence of dyslipidemias in
Mexico city and Its relation to other cardiovascular risk factors.
Results from the CARMELA study. Gac Med Mex. 150:128–136. 2014.(In
Spanish). PubMed/NCBI
|
|
57
|
Tóth PP, Potter D and Ming EE: Prevalence
of lipid abnormalities in the United States: The National Health
And Nutrition Examination Survey 2003–2006. J Clin Lipidol.
6:325–330. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Rodríguez-Villalobos E, Ramírez-Barba EJ
and Cervantes-Aguayo F: The incidence and opportunity for the
diagnosis of diabetic retinopathy. Salud Publica Mex. 36:275–280.
1994.(In Spanish). PubMed/NCBI
|
|
59
|
Chatziralli IP, Sergentanis TN,
Keryttopoulos P, et al: Risk factors associated with diabetic
retinopathy in patients with diabetes mellitus type 2. BMC Res
Notes. 3:1532010. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Prado-Serrano A, Guido-Jiménez M and
Camas-Benítez J: Prevalence of diabetic retinopathy in a Mexican
population. Rev Mex Oftalmol. 83:261–266. 2009.(In Spanish).
|
|
61
|
Kempen JH, O'Colmain BJ, Leske MC, et al
Eye Diseases Prevalence Research Group: The prevalence of diabetic
retinopathy among adults in the United States. Arch Ophthalmol.
122:552–563. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Smith TST, Szetu J and Bourne RR: The
prevalence and severity of diabetic retinopathy, associated risk
factors and vision loss in patients registered with type 2 diabetes
in Luganville, Vanuatu. Br J Ophthalmol. 91:415–419. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Kuo JZ, Wong TY and Rotter JI: Challenges
in elucidating the genetics of diabetic retinopathy. JAMA
Ophthalmol. 132:96–107. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Arsène S, Pouplard C, Perrodeau E, et al:
No association between the ITGA2 807T allele and retinopathy in
french patients with type 2 diabetes. Thromb Res. 128:293–295.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Jacquelin B, Tarantino MD, Kritzik M, et
al: Allele-dependent transcriptional regulation of the human
integrin alpha2 gene. Blood. 97:1721–1726. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Dinauer DM, Friedman KD and Hessner MJ:
Allelic distribution of the glycoprotein Ia (alpha2-integrin)
C807T/G873A dimorphisms among caucasian venous thrombosis patients
and six racial groups. Br J Haematol. 107:563–565. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Dodson PM, Haynes J, Starczynski J, et al:
The platelet glycoprotein Ia/IIa gene polymorphism C807T/G873A: A
novel risk factor for retinal vein occlusion. Eye (Lond).
17:772–777. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Gerger A, Hofmann G, Langsenlehner U, et
al: Integrin alpha-2 and beta-3 gene polymorphisms and colorectal
cancer risk. Int J Colorectal Dis. 24:159–163. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Wu G, Xi Y, Yao L, et al: Genetic
polymorphism of ITGA2 C807T can increase the risk of ischemic
stroke. Int J Neurosci. 124:841–851. 2014. View Article : Google Scholar : PubMed/NCBI
|
